HER2 Positive Breast Cancers with Progression

被引：0
|
作者：
Solanki, Malvika [1 ]
Chitambar, Christopher [2 ]
Jorns, Julie [3 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Med Coll Wisconsin, Affiliated Hosp, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
259
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
    Ding, Yi
    Gong, Chang
    Huang, De
    Chen, Rui
    Sui, Pinpin
    Lin, Kevin H.
    Liang, Gehao
    Yuan, Lifeng
    Xiang, Handan
    Chen, Junying
    Yin, Tao
    Alexander, Peter B.
    Wang, Qian-Fei
    Song, Er-Wei
    Li, Qi-Jing
    Wood, Kris C.
    Wang, Xiao-Fan
    NATURE COMMUNICATIONS, 2018, 9
  • [12] Hormonal prevention of HER2 positive mammary cancers
    Subramani, Ramadevi
    Lakshmanaswamy, Rajkumar
    CANCER RESEARCH, 2018, 78 (04)
  • [13] Breast Cancer Biomarker Changes and Correlations with HER2 Change in ER Positive, HER2 Negative Breast Cancers Treated with Neoadjuvant Endocrine Therapy
    Huang, Wei
    Tyburski, Haley
    Finkelman, Brian
    Turner, Bradley
    Weiss, Anna
    Dhakal, Ajay
    Skinner, Kristin
    Hicks, David
    Zhang, Huina
    LABORATORY INVESTIGATION, 2024, 104 (03) : S175 - S176
  • [14] Predictors of Response to Trastuzumab Containing Neoadjuvant Chemotherapy in HER2 Positive Breast Cancers
    Li, X.
    Kanbour-Shakir, A.
    Dabbs, D.
    Bhargava, R.
    MODERN PATHOLOGY, 2012, 25 : 49A - 50A
  • [15] Predictors of Response to Trastuzumab Containing Neoadjuvant Chemotherapy in HER2 Positive Breast Cancers
    Li, X.
    Kanbour-Shakir, A.
    Dabbs, D.
    Bhargava, R.
    LABORATORY INVESTIGATION, 2012, 92 : 49A - 50A
  • [16] JAM-A is over-expressed in aggressive Her2 positive breast cancers
    Brennan, K.
    Roche, T.
    McSherry, E. A.
    O'Grady, T.
    Kay, E. W.
    Hopkins, A. M.
    EJC SUPPLEMENTS, 2010, 8 (05): : 93 - 93
  • [17] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [18] Borderline HER2 Protein Positive Breast Cancers Have Similar Patient Outcome Regardless of HER2 Gene Amplification Status
    Barros, F.
    Aleskandarany, M.
    Rakha, E.
    Watts, S.
    Powe, D.
    Ellis, I
    Green, A.
    JOURNAL OF PATHOLOGY, 2010, 222 : S23 - S23
  • [19] BORDERLINE HER2 PROTEIN POSITIVE BREAST CANCERS HAVE SIMILAR PATIENT OUTCOME REGARDLESS OF HER2 GENE AMPLIFICATION STATUS
    Barros, F. F. T.
    Aleskandarany, M.
    Rakha, E.
    Watts, S. L.
    Powe, D. G.
    Ellis, I. O.
    Green, A. R.
    EJC SUPPLEMENTS, 2010, 8 (06): : 6 - 7
  • [20] The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
    Avisek Majumder
    Manbir Sandhu
    Debarko Banerji
    Veronica Steri
    Adam Olshen
    Mark M. Moasser
    Scientific Reports, 11
12345